Heavy Pharmaceutical Holdings (000950): Profits are under pressure in the short term, optimistic about gradual improvement
Heavy Pharmaceutical Holdings (000950): The company's operations are gradually improving, and the reform of state-owned enterprises continues to advance
Heavy Pharmaceutical Holdings (000950): Western Pharmaceutical Distribution Leader Benefiting from National Reform
Heavy Pharmaceutical Holdings (000950): The “14th Five-Year Plan” target of leading pharmaceutical distribution companies in the Midwest can be expected
Heavy Pharmaceutical Holdings (000950): Short-term performance is under pressure, and state-owned enterprise reform can be expected in the future
Heavy Pharmaceutical Holdings (000950): Steady growth in performance in the second quarter, impressive growth rate in the device sector
Heavy Pharmaceutical Holdings (000950): Q2 performance slightly exceeded expectations
Heavy Pharmaceutical Holdings (000950): A new leader in the distribution industry from the west to the whole country
Heavy Pharmaceutical Holdings (000950): 2019 H1 performance growth was strong, mixed reform of state-owned enterprises began
* ST Jianfeng (000950) comments: the Group's high-quality assets are injected into the fully transformed pharmaceutical circulation.
Jianfeng Chemical (000950): benefit from the recommended rating of shale gas production
[Changjiang Securities] Jianfeng Chemical Industry: benefit from the mass production of shale gas, recommend rating
[southwest Securities] Jianfeng Chemical Industry: gradually transformed into a New Chemical Materials Company
Jianfeng Chemical (000950): gradually transformed into a New Chemical Materials Company
Jianfeng Chemical (000950): management change does not change the company's management pattern
[China International Capital Corporation] Jianfeng Chemical: profit recovery in the second half of the year, maintain prudent recommendation
[China International Capital Corporation] Jianfeng Chemical: performance is lower than expected, maintain prudent recommendation
[Donghai Securities] Jianfeng Chemical Industry: the rising price of urea drives the company's performance growth.
【东海证券】建峰化工:成本上升挤压气头尿素利润空间
【中金公司】建峰化工:氮肥低迷仍将维持
No Data
No Data